It’s rare to hear good news about AIDS. This week, however, South Africa’s largest pharmaceutical company, Aspen Pharmacare, became the first to get the thumbs up from the Food and Drug Administration for a generic AIDS regimen.
...The U.S. government decided it couldn’t make other countries swallow what it wouldn’t give to its own citizens, and cheaper generic medicines that meet FDA safety standards can only help the U.S. anti-AIDS budget go further, says Stavros Nicolaou, Aspen’s senior executive in strategic trade.
No comments:
Post a Comment